Integrative Use of Sound Therapy for Mental Health Promotion
Integrative Use of Sound Therapy for Mental Health Promotion: A Randomized Clinical Trial
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
- Mental health disorders such as anxiety, stress, and depression are prevalent global health issues. Sound therapy is proposed as an integrative complementary therapy to address these conditions. This prospective randomized open-label study involves 110 participants.
- Participants will be randomized into:
> 1. *Intervention Group:* Receives sound therapy inside a specifically designed acoustic resonance chamber.
> 2. *Control Group:* Receives the same sound therapy sequence using headphones, without the chamber.
- The intervention consists of three weekly sessions of 9 minutes each. The sound protocol uses nine specific frequencies (ranging from 174 Hz to 936 Hz) derived from a 432 Hz tuning reference. Outcomes will be measured using validated scales including DASS-21, WHOQOL-Bref, and others at baseline, during the intervention, and at 30-day and 120-day follow-ups.
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brésil, 30130-100
- Federal University of Minas Gerais
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria
- Age over 18 years
- DASS-21 score consistent with at least mild anxiety, stress, or depression
- Agreement to complete the 3-week protocol and follow-up questionnaires
- Agreement not to practice other mind-body therapies during the study
- Maintenance of conventional medical and/or psychological treatments
Exclusion Criteria
- Normal scores on the DASS-21
- Presence of severe neurological, psychiatric, or clinical disorders
- Use of high doses of medication that prevent standing for 9 minutes
- Use of metal plates or devices in the body
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Acoustic Resonance Chamber
Participants listen to specific sound frequencies inside a cylindrical acoustic resonance chamber (190 cm high and 90 cm in diameter), designed to optimize sound pressure distribution.
Sessions last 9 minutes, once a week, for 3 weeks.
|
Participants will receive sound therapy in 3 sessions, one session per week, each lasting 9 minutes.
The protocol uses 9 sound frequencies as follows: session 1 will use the frequencies of 396 Hz (close to the note G), 639 Hz (close to the note E), and 963 Hz (close to the note B); session 2 will use the frequencies of 174 Hz (close to the note F), 417 Hz (close to the note G sharp), and 741 Hz (close to the note F sharp); and session 3 will use the frequencies of 285 Hz (close to the note D), 528 Hz (close to the note C), and 852 Hz (close to the note A), with each frequency applied for three minutes.
Sound therapy is performed inside an acoustic resonance chamber, designed to optimize sound pressure distribution.
|
|
Comparateur actif: Control Group with Headphones
Participants listen to exactly the same sound frequencies, for the same duration (9 minutes, once a week, for 3 weeks), using headphones while remaining seated in a chair, outside the acoustic chamber environment.
|
Participants will receive sound therapy in 3 sessions, one session per week, each lasting 9 minutes.
The protocol uses 9 sound frequencies as follows: session 1 will use the frequencies of 396 Hz (close to the note G), 639 Hz (close to the note E), and 963 Hz (close to the note B); session 2 will use the frequencies of 174 Hz (close to the note F), 417 Hz (close to the note G sharp), and 741 Hz (close to the note F sharp); and session 3 will use the frequencies of 285 Hz (close to the note D), 528 Hz (close to the note C), and 852 Hz (close to the note A), with each frequency applied for three minutes.
Participants receive the sound protocol through headphones, while remaining seated.
|
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from Baseline in Depression, Anxiety, and Stress Scores
Délai: Baseline, Day 7 post-intervention, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the 21-item Depression, Anxiety, and Stress Scale (DASS-21).
It assesses the severity of the core symptoms of depression, anxiety, and stress.
It consists of three subscales.
The total score for each subscale is calculated by summing the scores of the 7 relevant items (scored from 0 to 3) and multiplying by 2. Therefore, final scores for each subscale range from 0 to 42.
Higher scores indicate greater symptom severity.
|
Baseline, Day 7 post-intervention, Day 30 post-intervention, and Day 120 post-intervention.
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change from Baseline in Quality of Life
Délai: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the World Health Organization Quality of Life-BREF (WHOQOL-BREF).
The total scores for the domains are transformed to a scale ranging from 0 to 100.
Higher scores indicate a better quality of life.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Insomnia Severity
Délai: aseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Insomnia Severity Index (ISI).
Total scores range from 0 to 28.
Higher scores indicate more severe insomnia.
|
aseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Human Flourishing
Délai: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Harvard Human Flourishing Program measure.
The instrument consists of 12 items scored on a scale of 0 to 10.
The total score (Secure Flourish Index) ranges from 0 to 120.
Higher scores indicate a higher level of psychosocial prosperity and flourishing.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Religiosity
Délai: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Duke University Religion Index (DUREL).
The total score ranges from 5 to 27.
Higher scores indicate greater religious involvement and religiosity.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in General Health
Délai: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
ssessed using the 12-item General Health Questionnaire (GHQ-12).
It evaluates psychological distress and current mental health.
Scores are scaled from 0 to 36 (using the 0-1-2-3 Likert scoring method).
Higher scores indicate worse psychological well-being and higher levels of distress.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
|
Change from Baseline in Alcohol Use
Délai: Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Assessed using the Alcohol Use Disorders Identification Test (AUDIT).
This 10-item screening tool measures alcohol consumption, drinking behaviors, and alcohol-related problems.
Total scores range from 0 to 40.
Higher scores indicate more hazardous and harmful alcohol use.
|
Baseline, Day 30 post-intervention, and Day 120 post-intervention.
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Les enquêteurs
Les enquêteurs
- Chaise d'étude: Laylla CS Gendiroba, MSc, Federal University of Minas Gerais
- Chaise d'étude: UBIRATAN B Castro, MD, PhD, Federal University of Minas Gerais
- Chaise d'étude: Martinho M Sousa Filho, MD, MSc, Federal University of Minas Gerais
- Chercheur principal: Rubens L C Tavares, MD, PhD, Federal Universtiy of Minas Gerais
Publications et liens utiles
Publications générales
- Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, Pinzon V. [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref]. Rev Saude Publica. 2000 Apr;34(2):178-83. doi: 10.1590/s0034-89102000000200012. Portuguese.
- Aravena PC, Almonacid C, Mancilla MI. Effect of music at 432 Hz and 440 Hz on dental anxiety and salivary cortisol levels in patients undergoing tooth extraction: a randomized clinical trial. J Appl Oral Sci. 2020;28:e20190601. doi: 10.1590/1678-7757-2019-0601. Epub 2020 May 11.
- VanderWeele TJ. On the promotion of human flourishing. Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8148-8156. doi: 10.1073/pnas.1702996114. Epub 2017 Jul 13.
- Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J Affect Disord. 2014 Feb;155:104-9. doi: 10.1016/j.jad.2013.10.031. Epub 2013 Oct 28.
- Lucchetti G, Granero Lucchetti AL, Peres MF, Leao FC, Moreira-Almeida A, Koenig HG. Validation of the Duke Religion Index: DUREL (Portuguese version). J Relig Health. 2012 Jun;51(2):579-86. doi: 10.1007/s10943-010-9429-5.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Les troubles mentaux
- Symptômes comportementaux
- Comportement
- Satisfaction personnelle
- Troubles anxieux
- La dépression
- Stress, Psychologique
- Bien-être psychologique
- Techniques d'investigation
- Conception de la recherche épidémiologique
- Méthodes épidémiologiques
- Conception de la recherche
- Méthodes
- Groupes de contrôle
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- CAAE 84185724.2.0000.5149
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
- ANALYTIC_CODE
- RSE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .